The Federal Government has been negotiating with Pfizer and Moderna. It sounds like both are not keen to license their IP but I think Moderna is more accomodating to allow contract manufacturing, especially in fill and finish.
if we can negotiate with Moderna even for next year’s supply of 15 million doses that would be huge revenues for us. It could even be more than 15 million doses to cater for Asia pacific region. That would do nicely until we set up our own mRNA manufacturing.
Ann: Media Interest, MIPS COVID-19 Vaccine & Sterile Readiness, page-19
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $55.87M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 12.5¢ | $15.96K | 123.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 451665 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 538641 | 8 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IDT (ASX) Chart |